Nanoengineers at the University of California San Diego have developed COVID-19 vaccine candidates that can take the heat. Their key ingredients? Viruses from plants or bacteria.
A research team at the RIKEN Center for Emergent Matter Science (CEMS) in Japan has developed a diagnostic system that can rapidly and sensitively measure the amount of antibodies in the blood that can protect us from SARS-CoV-2, the virus that causes COVID-19.
Adults who have received a double vaccination are 49% less likely to have Long COVID should they contract a COVID-19 infection.
After two vaccines doses, the odds of hospitalisation were reduced by more than two-thirds and breakthrough infections were almost two times more likely to be completely asymptomatic.
Vaccinations against human papillomavirus (HPV), a major cause of throat and back of mouth cancers, are expected to yield significant reductions in the rates of these cancers in the U.S., but will not do so until after 2045, according to a new modeling study from researchers at the Johns Hopkins Bloomberg School of Public Health
A study measured effectiveness of COVID-19 mRNA vaccines among health workers, most notably during the emergence of delta virus variant and coincident with end of state’s mask mandate, finding protection waned over time, dropping sharply 6-8 months after full vaccination.
Vanderbilt University Hospital treated 39 pregnant patients hospitalized with active COVID-19 infections in August, 10 of whom were admitted to the intensive care unit (ICU).
SEATTLE — September 1, 2021 — Below are summaries of recent Fred Hutch research findings and other news.
UC San Diego is collaborating with San Ysidro Health on an NIH-funded outreach program to address COVID-19 vaccine hesitancy in Latinx and African American communities. The team runs pop-up vaccination sites across San Diego, and goes door-to-door to homes and local businesses to spread awareness.
Wistar welcomes Amelia Escolano, Ph.D., and Nan Zhang, Ph.D., as assistant professors.
Mayo Clinic Cancer Center announced on Tuesday, Aug. 31, that it is following recommendations from the National Comprehensive Cancer Network that encourage cancer patients to receive a third dose of a messenger RNA COVID-19 vaccine. The Moderna and Pfizer COVID-19 vaccines are messenger RNA vaccines.
News stories in this issue
As the delta variant surges across Los Angeles and the U.S., prominent civic leaders came together in a recent Cedars-Sinai virtual town hall and issued an urgent call to unvaccinated members of Latinx communities:
A primary analysis of an experimental HIV vaccine regimen being studied in a high-incidence population of young women in sub-Saharan Africa found the experimental vaccine did not provide sufficient protection against HIV infection.
Side effects clear up quickly in this group, findings show
Nearly 90% of people taking immunosuppressants to treat autoimmune conditions produce an antibody response to COVID-19 vaccination, but the response is weaker than those generated by healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.
A new study shows that two months after the second Pfizer/Moderna vaccination, antibody response decreases 20% in adults with prior cases of COVID-19. The study also tests how well current vaccines resist emerging variants.
The Ohio State University Wexner Medical Center is aggressively working to address health care inequities and protect the health of all people, starting with initiatives to improve access to flu vaccines.
Science teachers learned techniques to study how cells work through a four-day synthetic biology workshop at South Dakota State University. Those lessons, including how mRNA vaccines work, aim to help the teachers get their students excited about cutting-edge science.
NCI-designated cancer centers, AACI members and other cancer centers and medical groups endorse HPV vaccination and cancer screening to eliminate cancers caused by the virus.
National Comprehensive Cancer Network (NCCN) Vaccination Advisory Committee updates recommendations for vaccinating people with cancer against COVID-19 based on regulatory changes and emerging data regarding third doses (aka boosters).
Pregnant women hospitalized with COVID-19 had improved recovery outcomes after delivering their babies early, according to new research from The University of Texas Health Science Center at Houston (UTHealth).
A Michigan Medicine physician will co-lead a NIH study of antibody response to an additional dose of the COVID-19 vaccine in people with autoimmune disease. The trial will also assess whether pausing immunosuppressive medication improves immune response to the booster shot.
PHILADELPHIA – For their landmark research that set a foundation for the mRNA SARS-CoV-2 vaccines, Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research, and Katalin Karikó;, PhD, an adjunct professor of Neurosurgery at the Perelman School of Medicine at the University of Pennsylvania and a senior vice president at BioNTech, have been selected to receive the 2021 Albany Prize.
COVID-19 vaccines remain effective, but their potency has diminished in recent months, according to a nationwide study at eight sites, including Salt Lake City, Utah.
In the podcast and video show “War Room” hosted by Steve Bannon, Dr. Robert Malone claimed that the "mainstream media is lying" and suggested that the vaccine that was approved by the FDA is somehow different than the "Pfizer vaccine" currently available under emergency use authorization.
Individuals with COVID-19 are most likely to spread the virus to close contacts two days before the onset of symptoms to three days after symptoms appear, and the risk of transmission is highest when patients had mild or moderate disease severity, according to a new study by researchers at the University of Georgia.
Just as the moves to protect students by keeping them at home required them to weather some detrimental effects, their return this fall carries new risks. Two Penn State Health doctors discuss how you can keep your kids safe this fall.
Fertility and pregnancy were often stressful topics even before the COVID-19 pandemic began, but now, many who are pregnant or hoping to become pregnant have questions about how to protect themselves from the virus while keeping their reproductive goals in mind.
A new study out in the Clinical Infectious Diseases journal demonstrates how quickly COVID-19 can spread through a household, and provides insight into how and why communities of color have suffered disproportionately from the pandemic.
The breast milk of lactating mothers vaccinated against COVID-19 contains a significant supply of antibodies that may help protect nursing infants from the illness, according to new research from the University of Florida.
August 16, 2021 – Chulalongkorn Memorial Hospital, Thai Red Cross Society, and the Vaccine Research Center, Faculty of Medicine, Chulalongkorn University (CVRC) held a press conference on the progress of clinical trials for the Thai “ChulaCov19” mRNA vaccine. The clinical trial (Phase 1) was administered in healthy volunteers who are found to have good immunity after they have been vaccinated. The volunteers’ antibodies have been greatly boosted to prevent the original strain of the virus, and four other variants, namely Alpha, Beta, Gamma, and Delta. Manufacturing and preparation for registration to be used in an emergency are underway.
Atrium Health Wake Forest Baptist and its healthtech business enterprise operated through the Innovation Quarter, iQ Healthtech Labs, are taking COVID-19 vaccination efforts to new heights with drone deliveries – the first COVID-19 vaccine drone delivery program in the country.
Rutgers School of Public Health dean, Perry N. Halkitis, and Center for Health, Identity, Behavior and Prevention Studies deputy director, Kristen D. Krause, have received a grant from the Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) Investigator Studies Program (MISP) to examine COVID-19 and HPV vaccine uptake in sexual and gender minority populations living in New Jersey.
Emphasizing individual rather than community health risks from COVID-19, appeared to create more vaccine acceptance among participants in a study led by Washington State University researcher Porismita Borah.
In a large-scale, population-based surveillance conducted in partnership with the City of Santa Ana, researchers at the University of California, Irvine’s Program in Public Health found 27% positivity of SARS-CoV-2 antibodies among participating Santa Ana residents. This unique study was one of the first to examine household transmission of COVID-19 and to include a pediatric population (ages 5+).
For more than 40 years, UCI infectious disease researcher Michael Buchmeier has studied coronaviruses, and he’s one of the leading experts on SARS-CoV-2, the version of the virus causing the COVID-19 pandemic. As a more lethal mutation of the virus, called the delta variant, sparks another wave of cases, he offers his expertise about this threat.
California State University Chancellor Joseph I. Castro released the following statement on the FDA's approval of the Pfizer vaccine.
Marc Incerpi, MD, obstetrician and gynecologist with Keck Medicine of USC and chief of maternal-fetal medicine at the Keck School of Medicine of USC, answers questions about why getting the vaccine is so important and addresses other crucial issues for expectant moms.
PHILADELPHIA – The U.S. Food and Drug Administration (FDA) has given the first full approval to a COVID-19 mRNA vaccine, which uses modified mRNA technology invented and developed by scientists in the Perelman School of Medicine at the University of Pennsylvania, whose years of research in mRNA science laid a critical piece of the foundation for the largest global vaccination campaign in history.
Today, the US Food & Drug Administration approved the two-dose COVID-19 Pfizer-BioNTech vaccine. Jesse L. Goodman, MD, MPH, professor of medicine and infectious diseases at Georgetown University Medical Center and former FDA Chief Scientist comments. (Audio file available)
Researchers at Washington University School of Medicine in St. Louis have identified an antibody that is highly protective against a broad range of viral variants.
What is it like for healthcare professionals to face yet another COVID-19 surge, when many of their sickest patients are unvaccinated against the virus that causes COVID-19? The Cedars-Sinai Newsroom team reached out to some of our #HealthcareHeroes to find out.
A new study in Frontiers in Public Health presents a review of expert opinions on the achievements and shortcomings of the European Union’s (EU) COVID-19 response.
A monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca reduced the risk of symptoms in a study of immunocompromised and chronically ill adults later exposed to the virus by 77%, the company announced today.
The early COVID-19 vaccination campaign in the U.S. prevented nearly 140,000 deaths and 3 million cases of COVID-19 by the second week of May, according to a new study.
National Comprehensive Cancer Network (NCCN) COVID-19 Vaccination Advisory Committee calls for healthcare workforce vaccine requirements to assure healthcare community is doing all it can to prevent exposure to COVID-19.
Offering covid-19 vaccinations on campus, delayed or phased autumn re-openings, and mandatory face mask wearing are among the steps universities and colleges could take to make them safer places for students returning to, or starting, their studies this autumn, say public health experts in an opinion piece in The BMJ.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
